{"schema_version":"secwatch.filing_event.v1","accession":"0000885725-26-000006","form_type":"8-K","ticker":"BSX","cik":"0000885725","company_name":"BOSTON SCIENTIFIC CORP","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.919803+00:00","generated_at":"2026-05-16T05:11:40.172524+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Boston Scientific reports Q4 and full year 2025 results, announces acquisitions","bullets":["Q4 2025 net sales $5.286B, up 15.9% reported; GAAP EPS $0.45, adjusted EPS $0.80.","FY2025 net sales $20.074B, up 19.9%; GAAP net income $2.898B, adjusted EPS $3.06.","Agreed to acquire Penumbra (PEN), a thrombectomy and neurovascular company.","Agreed to acquire Valencia Technologies for its eCoin tibial nerve stimulation device.","Completed acquisition of Nalu Medical for peripheral nerve stimulation system."],"urls":{"canonical":"https://secwatch.observer/filing/0000885725-26-000006","json":"https://secwatch.observer/filing/0000885725-26-000006.json","markdown":"https://secwatch.observer/filing/0000885725-26-000006.md","text":"https://secwatch.observer/filing/0000885725-26-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885725/000088572526000006/0000885725-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885725/000088572526000006/bsx-20260204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T05:11:40.172524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}